Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza – Tender Specifications – Lot 2 OJ/2021/DPR/12924  with support from ECDC. ECDC will decide which countries to be offered  whole genome sequencing support.  • In addition, the contractor should ensure that all participating laboratories,  performing the molecular and serology diagnostics, are producing comparable results and are taking part to a standardisation assessment,  which will be agreed with ECDC.  • Study sites should preferably reflect a fair geographical representation of  the European Union/European Economic Area.  The contractor will take care of ensuring submission of study ethical approvals and  of ensuring provision of informed consent to all study participants.  DL 2.2.3. Report  describing all  participating study  sites with standard  template across sites  The contractor will provide a report describing all the participating study sites  using a standard template for all sites.  The report will include a full list of participating hospitals/units with a named focal  point (i.e. a site-specific study investigator), each hospital/unit’s type and size,  number of healthcare workers eligible for study recruitment stratified by role/risk  of exposure to SARS-CoV-2, laboratory and testing capacity, status of COVID-19  vaccination campaign, and other ongoing or planned studies on COVID-19 at the  same study site.  Every two years  Word - ECDC  template  Power point  DL 2.2.4. Hospital/  site specific Standard  Operating  Procedures to  implement the  EU/EEA protocol. Standard Operating Procedures (SOPs) for study sites joining the study.  The SOPs will be in the respective national language(s) of the countries, unless  otherwise agreed with the countries (to be documented and sent to ECDC), with an  English summary.  Dependent on new  countries/study sites Word  DL 2.2.5. Regular  epidemiological data  update. Collection and validation of datasets, and production of regular epidemiological  updates.  The deliverable should consist of a validated dataset, scripts, and a summary table  covering all study sites. The summary table shall include the number of events  On a monthly basis  Word and format  compatible with  statistical software  (e.g. STATA, R, csv) 